Leukemia Research
Volume 27, Issue 7 , Pages 643-648 , July 2003

Analysis of HLA-G expression in malignant hematopoetic cells from leukemia patients

  • Katarı́na Poláková

      Affiliations

    • Cancer Research Institute, Slovak Academy of Sciences, Vlárska 7, 83391 Bratislava, Slovak Republic
    • Corresponding Author InformationCorresponding author. Fax: +421-2-59327-250.
    • ,
  • Martina Kŕčová

      Affiliations

    • Institute of Virology, Slovak Academy of Sciences, Dúbravská cesta 9, 84245 Bratislava, Slovak Republic
    • ,
  • Daniel Kuba

      Affiliations

    • Slovak Centre for Organ Transplantation, Institute of Preventive and Clinical Medicine, Limbová 14, 83301 Bratislava, Slovak Republic
    • ,
  • Gustáv Russ

      Affiliations

    • Institute of Virology, Slovak Academy of Sciences, Dúbravská cesta 9, 84245 Bratislava, Slovak Republic

Received 12 July 2002 ,Accepted 3 August 2002.

References 

  1. Loke YW, Hiby S, King A. Human leukocyte antigen-G and reproduction. J. Reprod. Immunol. 1999;43:235–242
  2. Blaschitz A, Lenfant F, Mallet V, Hartmann M, Bensussan A, Geraghty DE, et al.  Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G. Eur. J. Immunol. 1997;27:3380–3388
  3. Schust DJ, Tortorella D, Ploegh HL. HLA-G and HLA-C at the feto-maternal interface: lessons learned from pathogenic viruses. Semin. Cancer Biol. 1998;9:37–46
  4. King A, Burrows TD, Hiby SE, Bowen JM, Joseph S, Verma S, et al.  Surface expression of HLA-C antigen by human extravillous trophoblast. Placenta. 2000;21:376–387
  5. Cabestre FA, Lefebvre S, Moreau P, Rouas-Friess N, Dausset J, Carosella ED, et al.  HLA-G expression: immune privilege for tumour cells?. Semin. Cancer Biol. 1999;9:27–36
  6. O’Callaghan CA, Bell JI. Structure and function of the human class Ib molecules HLA-E, HLA-F and HLA-G. Immunol. Rev. 1998;163:129–138
  7. Wiendl H, Mitsdoerffer M, Hofmeister V, Wischhusen J, Bornemann A, Meyermann R, et al.  A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. J. Immunol. 2002;168:4772–4780
  8. Paul P, Cabestre FA, LeGal FA, Khalil-Daher I, LeDanff C, Schmid M, et al.  Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies. Cancer Res. 1999;59:1954–1960
  9. Mizuno S, Emi N, Kasai M, Ishitani A, Saito H. Aberrant expression of HLA-G antigen in interferon gamma-stimulated acute myelogenous leukaemia. Br. J. Haematol. 2000;111:280–282
  10. Wagner SN, Rebmann V, Willers CP, Grosse-Wilde H, Goos M. Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma. Lancet. 2000;356:220–221
  11. Urosevic M, Kurrer MO, Kamarashev J, Mueller B, Weder W, Burg G, et al.  Human leukocyte antigen G up-regulation in lung cancer associates with high grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am. J. Pathol. 2001;159:817–824
  12. Urosevic M, Willers J, Mueller B, Kempf W, Burg G, Dummer R. HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood. 2002;99:609–617
  13. Amiot L, Onno M, Drenou B, Monvoisin C, Fauchet R. HLA-G class I gene expression in normal and malignant hematopoietic cells. Hum. Immunol. 1998;59:524–528
  14. Lefebvre S, Moreau P, Guiard V, Ibrahim EC, Adrian-Cabestre F, Menier C, et al.  Molecular mechanisms controlling constitutive and IFN-γ-inducible HLA-G expression in various cell types. J. Reprod. Immunol. 1999;43:213–224
  15. Real LM, Cabrera T, Canton J, Oliva R, Ruiz-Cabello F, Garrido F. Looking for HLA-G expression in human tumors. J. Reprod. Immunol. 1999;43:263–273
  16. Paul P, Rouas-Freiss N, Moreau P, Cabestre FA, Menier C, Khalil-Daher L, et al.  HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression. Hum. Immunol. 2000;61:1177–1195
  17. Ishitani A, Geraghty DE. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class I antigens. Proc. Nat. Acad. Sci. U.S.A. 1992;89:3947–3951
  18. Mallet V, Pröll J, Solier C, Aguerre-Girr M, DeRossi M, Loke YW, et al.  The full length HLA-G1 and no other alternative form of HLA-G is expressed at the cell surface of transfected cells. Hum. Immunol. 2000;61:212–224
  19. Bainbridge DR, Ellis SA, Sargent IL. The short forms of HLA-G are unlikely to play a role in pregnancy because they are not expressed at the cell surface. J. Reprod. Immunol. 2000;47:1–16
  20. McMaster M, Zhou Y, Shorter S, Kapasi K, Geraghty D, Lim KH, et al.  HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation. J. Immunol. 1998;160:5922–5928
  21. Amiot L, Onno M, Lamy T, Dauriac C, Le Prise PY, Fauchet R, et al.  Loss of HLA molecules in B lymphomas is associated with an agressive clinical course. Br. J. Haematol. 1998;100:655–663
  22. Jimenez P, Canton J, Collado A, Cabrera T, Serrano A, Real LM, et al.  Expression of HLA-G in tumors is not a frequent event. Int. J. Cancer. 1999;81:512–518
  23. Pangault C, Amiot L, Caulet-Maugendre S, Brasseur F, Guilloux V, Drenou B, et al.  HLA-G protein expression is not induced during malignant transformation. Tissue Antigens. 1999;53:335–346
  24. Frumento G, Franchello S, Palmisano GL, Nicotra MR, Giacomini P, Loke YW, et al.  Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by gamma IFN treatment. Tissue Antigens. 2000;56:30–37
  25. Davies B, Hiby S, Gardner L, Loke YW, King A. HLA-G expression by tumors. Am. J. Reprod. Immunol. 2001;45:103–107
  26. Polakova K, Russ G. Expression of the non-classical HLA-G antigen in tumor cell lines is extremely restricted. Neoplasma. 2000;47:342–348

PII: S0145-2126(02)00228-X

doi: 10.1016/S0145-2126(02)00228-X

Leukemia Research
Volume 27, Issue 7 , Pages 643-648 , July 2003

Article Tools

* Image Usage & Resolution